SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001632237-20-000001
Filing Date
2020-03-05
Accepted
2020-03-05 18:46:27
Documents
1
Period of Report
2020-03-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5752
  Complete submission text file 0001632237-20-000001.txt   7242
Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address
Benaim Ely (Reporting) CIK: 0001632237 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37565 | Film No.: 20692095

Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Issuer) CIK: 0001645113 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus